发明名称 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE
摘要 Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.
申请公布号 US2017015703(A1) 申请公布日期 2017.01.19
申请号 US201615279146 申请日期 2016.09.28
申请人 AGIOS PHARMACEUTICALS, INC 发明人 Popovici-Muller Janeta;Lemieux Rene M.;Travins Jeremy;Cai Zhenwei;Cui Dawei;Zhou Ding
分类号 C07K5/065;A61K38/05;A61K38/00 主分类号 C07K5/065
代理机构 代理人
主权项 1. A compound of formula I or a pharmaceutically acceptable salt, tautomer, isotopologue or hydrate thereof, wherein: R1 is optionally substituted C4-C6 carbocyclyl; each R2 and R3 is independently selected from optionally substituted aryl or optionally substituted heteroaryl; R4 is alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aralkyl, or optionally substituted heteroaralkyl; ring A is 4-6 membered non-aromatic ring having 0-1 additional heteroatoms selected from N, O or S, wherein ring A is optionally substituted with one or two R5 groups; each R5 is independently halo; —CF3; —CN; —OR6; —N(R6)2; —C(O)C1-C4 alkyl; C1-C4 haloalkyl; C1-C4 alkyl optionally substituted with —OR6 or —N(R6)2; —O—C1-C4 alkyl optionally substituted with halo, —OR6 or —N(R6)2; —SO2N(R6)2; —SO2(C1-C4 alkyl); —NR6SO2R6; C3-C5 carbocyclyl optionally substituted with one or two R6 groups; —O—(C3-C6 carbocyclyl optionally substituted with one or two R6 groups); 5-6 membered heteroaryl; —C1-C4 alkyl-C(O)O—C1-C4 alkyl; or —C(O)O—C1-C4 alkyl; or each R6 is independently H or C1-C3 alkyl.
地址 Cambridge MA US